These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9293422)

  • 21. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic renal disease: from recent studies to improved clinical practice.
    Mogensen CE; Cooper ME
    Diabet Med; 2004 Jan; 21(1):4-17. PubMed ID: 14706048
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New antihypertensive therapy in diabetics].
    Passa P; Marre M; Leblanc H; Billault B
    Diabete Metab; 1987; 13(6):643-50. PubMed ID: 3329128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertension treatment in patients with diabetes].
    Duława J
    Przegl Lek; 1997; 54(11):777-80. PubMed ID: 9501688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S
    J Assoc Physicians India; 1995 Jul; 43(7):517-8. PubMed ID: 8713236
    [No Abstract]   [Full Text] [Related]  

  • 30. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprophylaxis of diabetic nephropathy in the elderly.
    Jungmann E
    Drugs Aging; 1996 Dec; 9(6):449-57. PubMed ID: 8972244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
    Schnack C; Schernthaner G
    Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive therapy in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S86-90. PubMed ID: 1360846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of diabetic nephropathy].
    Stahl RA; Schoeppe W; Thaiss F
    Z Kardiol; 1993; 82 Suppl 4():45-8. PubMed ID: 8147061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic nephropathy: evidence for renoprotection and practice.
    Mogensen CE
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i26-8:discussion i50. PubMed ID: 10956317
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlling hypertension in patients with diabetes.
    Konzem SL; Devore VS; Bauer DW
    Am Fam Physician; 2002 Oct; 66(7):1209-14. PubMed ID: 12387432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.